Perception of Doctors towards Relationship with Pharmaceutical Industry

Keywords: Pharmaceutical companies, Doctor-Pharma Regulations, Abbas Institute of Medical Sciences (AIMS).


Introduction: Doctors and pharmaceutical companies are the major components of the health care system. Their interdependency on such a large scale calls for a better relationship between two stakeholders of the health care system. Most of the time the relationship has a bad impact on the reputation of the prestigious medical profession as well as affects the health of the poor patient causing the malafied relationship.
Materials and Methods: In order to see how the relationship works in the hospitals of Azad Kashmir, the study was conducted on the doctors of Abbas Institute of Medical Sciences, Muzaffarabad. A mixed type of study was conducted from January through June 2017. In this study, 100 doctors were selected for data collection by questionnaire method. While three different focus groups involving doctors from different specialties were made.
Results: Out of 100 doctors, 36 doctors agreed that the doctors in AIMS are aware of such guidelines, 92 doctors agreed that there is a need for national guidelines to monitor the doctor and pharmaceutical company’s relationship, and 67 responded that doctors' prescription is influenced by the gifts given by pharmaceutical companies, 52 doctors agreed that pharmaceutical companies should be banned from giving gifts to physicians, 88 responded that the information provided by those representatives is only superficial and they don’t know the core information like side effects and mode of action of the drugs, 15 thought that yes it is ethical to accept the gifts from the pharmaceutical companies but only to the extent of samples of medicines. Out of 100, 89 doctors responded in favor of the incorporation of bioethics in the curriculum of medical education. During focus group discussion on the topic, three themes were finalized after detailed deliberation and these themes were, Doctor-Pharma Regulations, Accepting the gifts from Pharmaceutical Companies, and the influence of these Interactions on Physicians’ drug prescribing Behaviors and how the prescribing behaviors of doctors.
Conclusion: Pharmaceutical companies have hijacked our whole health system to some extent and are polluted because of these Pharmaceutical companies’ representatives. There is a need to ascertain the fact that if this phenomenon is not controlled, in near future we will have to face very severe consequences and our patients will be at the mercy of pharmaceutical companies rather than the doctor.


1. Moynihan R. Who pays for pizza? Redefining the relationships between doctors and drug companies. BMJ, 2003;326:1189-1192.
2. Imran Asif, Shehzad Amin. The Impact of Doctor–Pharma Relationships on Prescribing Practice. Journal of Basic & Applied Sciences, 2012, 8, 174-180
3. ShahuIngole, Radha Yegnanarayan. International Journal of Pharma Sciences and Research (IJPSR), Vol.2(2), 2011, 49-57
4. Lexchin J. What information do physicians receive from pharmaceutical representatives? Can Fam Physician, 1997; 43: 941-5.
5. Wazana A. Physicians and the pharmaceutical industry, is a gift ever just a gift? JAMA, 2000; 283: 373-80.
6. Greenberg RD. Conflicts of Interest: can a physician serve two masters? Clin Dermatol, 2012;30:160–73.
7. Robbins NM. Ethical issues pertaining to conflicts of interest between neurologists and the pharmaceutical and medical device industries. Semin Neurol.2018;38:589–98.
8. Wazana A. Physicians and the pharmaceutical industry: isa gift ever just a gift? JAMA.2000;283:373–80.
9. Fadlallah R, Alkhaled L, Brax H, Nasser M, Rajabbik MH, Nass H, et al. Extent of physician-pharmaceutical industry interactions in low- and middle-income countries: systematic review. Eur J Public Health.2018;28:224–30.
10. Green MJ, Masters R, James B, Simmons B, Lehman E. Do gifts from the pharmaceutical industry affect trust in physicians? Fam Med.2012;44:325–31.
11. Lexchin J. Interactions between physicians and the pharmaceutical industry: what does the literature say? CMAJ.1993;149:1401–7.
12. Niles S. Sales force effectiveness (the third in a series of articles that examine problems and solutions of detail in to physicians). Med Ad News.2015;24:1.
13. Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff (Millwood). 2000;19:110–28.
14. Saito S, Mukohara K, Bito S. Japanese practicing physicians' relationships with pharmaceutical representatives: a national survey. PLoS One. 2010;5: 12193.
15. McKinney WP, Schiedermayer DL, Lurie N, Simpson DE, Goodman JL, Rich EC. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA.1990;264:1693–7.
16. Imran Asif and Shehzad Amin. The Impact of Doctor–Pharma Relationships on Prescribing Practice. Journal of Basic & Applied Sciences, 2012, 8, 174-180.
17. Marisa D. A. Amir J. Sualeha S. and Nikolina A. The ethics of pharma-physician relations in Pakistan. Ethics and behavior., 2019; 29(6)., 473-489.
18. IA Raja and Chaudary MR. “Islam and Medical Ethics.” ActaNeurochir 74(1999), 29-34.
19. Hneine B, Racha F, Lara AK, Hala N, and Elie AA. Association between physicians’ interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis. Plos One; 2017;
20. Mustafa A. Alssageer& Stefan R. Kowalski (2012) Doctors’ opinions of information provided by Libyan pharmaceutical company representatives, Libyan Journal of Medicine, 7:1.
21. Deborah K. Salomeh K. and Joseph S. R. Physician Attitudes Toward Industry A View Across the Specialties. Arch Surg. 2010;145(6):570-577.
22. Tabinda A, Aiesha I, Faisal S and Fahad S. Knowledge and perception about bioethics: A comparative study of private and government medical college students of Karachi Pakistan. Journal of family medicine and primary care., 2021; 10(3); 1161-1166.
How to Cite
Ahmad M, Zaka N, Rahman I, Mumtaz S, Dodhy M, Meraj L. Perception of Doctors towards Relationship with Pharmaceutical Industry. JRMC [Internet]. 30Jun.2022 [cited 24Sep.2022];26(2):321-9. Available from:

Most read articles by the same author(s)